[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  FloatRaider [@FLOATRAIDER](/creator/twitter/FLOATRAIDER) on x XX followers Created: 2025-07-10 12:53:17 UTC GLMD 🚨 Price at $XXXX — broke key level with power. Final catalyst July 27: licensing global rights to oral sublingual semaglutide. Small float, big upside if deal lands. Massive GLP‑1 market ahead. $ECO $PSIX $CNAF $SNX $CDZI $PPIH $RXT $LSB $ARBE $ALRN $OPTX $DAL $FRO XXX engagements  **Related Topics** [dal](/topic/dal) [snx](/topic/snx) [$optx](/topic/$optx) [$alrn](/topic/$alrn) [$arbe](/topic/$arbe) [$lsb](/topic/$lsb) [$rxt](/topic/$rxt) [$ppih](/topic/$ppih) [Post Link](https://x.com/FLOATRAIDER/status/1943292441789890735)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
FloatRaider @FLOATRAIDER on x XX followers
Created: 2025-07-10 12:53:17 UTC
GLMD 🚨 Price at $XXXX — broke key level with power. Final catalyst July 27: licensing global rights to oral sublingual semaglutide. Small float, big upside if deal lands. Massive GLP‑1 market ahead. $ECO $PSIX $CNAF $SNX $CDZI $PPIH $RXT $LSB $ARBE $ALRN $OPTX $DAL $FRO
XXX engagements
/post/tweet::1943292441789890735